howard (jack) west, md, regarding the combination of immunotherapy & chemotherapy in nsclc
Published 6 years ago • 53 plays • Length 4:21
Download video MP4
Download video MP3
Similar videos
-
2:08
howard (jack) west, md, on treatment options for patients who progress on i-o & chemotherapy
-
2:28
howard (jack) west, md, regarding pdl-1 expression and nsclc
-
3:01
jack west, md, on anti-pd-l1/pd-1 therapy in combination with chemotherapy & targeted therapies
-
3:13
howard (jack) west, md, discusses key takeaways from the impower150 study in nsclc
-
3:32
jack west, md, discusses possible immunotherapy combination treatments in the near future
-
1:52
howard (jack) west, m.d., at #asco20
-
3:20
howard (jack) west, md, regarding tumor mutation burden (tmb) as a biomarker for nsclc patients
-
2:26
howard (jack) west, md, on maintenance therapy after carboplatin, pemetrexed & pembrolizimab
-
29:45
immunotherapy in lung cancer with dr. jack west, part 1
-
4:35
immunotherapy combinations
-
2:49
jack west, md, discusses pd-l1/pd-1 therapy in lung cancer treatment algorithms
-
4:01
locally advanced nsclc: looking ahead
-
5:25
optimizing the pacific regimen
-
1:47
howard (jack) west, m.d.
-
6:40
chemotherapy/immunotherapy combinations in lung cancer
-
6:52
combination chemotherapy and immunotherapy for patients with high pd-l1 nsclc - 2022 program: lcvl
-
28:55
immunotherapy in lung cancer with dr. jack west, part 2
-
1:00
chemotherapy and immunotherapy combinations are the future of nsclc treatment
-
1:13
jack west, md, shares his outlook on ido inhibitors for treatment of lung cancer
Clip.africa.com - Privacy-policy